Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
Condition(s):Deep Vein ThrombosisLast Updated:February 22, 2007Completed
Hide Studies Not Open or Pending
Condition(s):Deep Vein ThrombosisLast Updated:February 22, 2007Completed
Condition(s):Deep Vein ThrombosisLast Updated:April 13, 2017Completed
Condition(s):Paget Schroetter SyndromeLast Updated:June 6, 2018Unknown status
Condition(s):Venous Thrombosis; PregnancyLast Updated:December 9, 2021Unknown status
Condition(s):Pulmonary EmbolismLast Updated:February 27, 2014Completed
Condition(s):Lower Extremity Deep Vein ThrombosisLast Updated:January 12, 2023Completed
Condition(s):Deep Vein Thrombosis LegLast Updated:July 7, 2011Completed
Condition(s):Venous Thrombosis; Pulmonary EmbolismLast Updated:December 10, 2010Withdrawn
Condition(s):Deep Vein Thrombosis, Pulmonary EmbolusLast Updated:July 27, 2023Completed
Condition(s):Venous ThrombosisLast Updated:May 20, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.